Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica
1 clinical trials · Sponsor
◉ Watch Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica
| Record | Firm | Date |
|---|---|---|
| Study of Intravenous TAD® 600 Mg/4 ML Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial Injury in Patients with Pneumonia. (NCT06296212) | Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica | 2024-06-25 |
Track Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica automatically
Every clearance here is in the API, with alerts when new ones post.